ArcherDX: Natera Files Additional Suit Against ArcherDX

SAN CARLOS, Calif., Aug. 7, 2020 /PRNewswire/ - Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, filed suit yesterday against ArcherDX, Inc. for infringement of Natera's U.S. Patent No. 10,731,220 (the "'220 Patent"). The complaint was filed in the U.S. District Court of Delaware.The '220 Patent is titled "Methods for Simultaneous Amplification of Target Loci" and was issued by the United States Patent and Trademark Office on August 4, 2020. The '220 Patent is one of more than 200 patents issued or pending in Natera's global intellectual property ...Read The Full Article On MicroSmallCap.comGet early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.